StemRIM Inc. Logo

StemRIM Inc.

Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.

4599 | T

Overview

Corporate Details

ISIN(s):
JP3399690001
LEI:
Country:
Japan
Address:
茨木市彩都あさぎ7丁目7番15号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

StemRIM Inc. is a biotechnology company engaged in the research and development of a next-generation class of regenerative medicine called "Regeneration-Inducing Medicine™". Originating as a venture from Osaka University, the company focuses on developing drugs with a novel mechanism of action. This approach aims to maximize the body's innate ability to repair itself by recruiting a patient's own in-vivo stem cells to damaged tissues, thereby inducing functional regeneration without conventional cell-therapy. The company's drug development pipelines target intractable diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 06:38
Registration Form
有価証券届出書(参照方式)
Japanese 49.2 KB
2025-10-21 08:10
Registration Form
確認書
Japanese 8.1 KB
2025-10-21 08:10
Annual Report
有価証券報告書-第20期(2024/08/01-2025/07/31)
Japanese 2.7 MB
2025-09-12 05:32
Share Issue/Capital Change
訂正臨時報告書
Japanese 30.7 KB
2025-03-13 04:31
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-03-13 04:30
Interim Report
半期報告書-第20期(2024/08/01-2025/07/31)
Japanese 228.6 KB
2024-11-25 08:13
Registration Form
有価証券届出書(参照方式)
Japanese 49.5 KB
2024-11-18 01:31
Share Issue/Capital Change
訂正臨時報告書
Japanese 32.6 KB
2024-11-13 08:10
Regulatory News Service
臨時報告書
Japanese 36.2 KB
2024-10-31 05:28
Post-Annual General Meeting Information
臨時報告書
Japanese 22.4 KB
2024-10-31 03:35
Governance Information
内部統制報告書-第19期(2023/08/01-2024/07/31)
Japanese 21.0 KB
2024-10-31 03:35
Registration Form
確認書
Japanese 8.1 KB
2024-10-31 03:32
Annual Report
有価証券報告書-第19期(2023/08/01-2024/07/31)
Japanese 2.7 MB
2024-07-26 08:53
Regulatory News Service
臨時報告書
Japanese 35.7 KB
2024-07-26 08:53
Regulatory News Service
臨時報告書
Japanese 35.8 KB

Automate Your Workflow. Get a real-time feed of all StemRIM Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for StemRIM Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for StemRIM Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

SELLAS Life Sciences Group, Inc. Logo
Late-stage biopharma developing novel immunotherapies for a broad range of cancers.
United States of America
SLS
Sensei Biotherapeutics, Inc. Logo
Developing tumor-activated biologics to stimulate a targeted immune response against cancer.
United States of America
SNSE
Senti Biosciences, Inc. Logo
Developing smart cell and gene therapies with Gene Circuits to precisely target cancer.
United States of America
SNTI
SEOUL PHARMA CO.,LTD Logo
Develops pharmaceuticals with innovative Orally Disintegrating Film (ODF) tech for global markets.
South Korea
018680
Septerna, Inc. Logo
Advancing novel small molecule GPCR medicines for endocrine, immune, and metabolic diseases.
United States of America
SEPN
SERA PROGNOSTICS, INC. Logo
Develops predictive blood tests to assess preterm birth risk and improve pregnancy outcomes.
United States of America
SERA
Seres Therapeutics, Inc. Logo
Developing live biotherapeutics from the microbiome to treat infections and immune diseases.
United States of America
MCRB
Serina Therapeutics, Inc. Logo
Developing safer, more effective drugs for neurology and cancer using polymer technology.
United States of America
SER
SEYİTLER KİMYA SANAYİ A.Ş. Logo
Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.
Türkiye
SEYKM
Shaperon Inc. Logo
Develops inflammasome inhibitors & nanobodies for inflammatory diseases and cancer.
South Korea
378800

Talk to a Data Expert

Have a question? We'll get back to you promptly.